ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

UPS Upstream

1.625
0.00 (0.00%)
Share Name Share Symbol Market Type Share ISIN Share Description
Upstream LSE:UPS London Ordinary Share KYG7393S1012 ORD 0.25P (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.625 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Upstream Share Discussion Threads

Showing 5351 to 5365 of 5500 messages
Chat Pages: 220  219  218  217  216  215  214  213  212  211  210  209  Older
DateSubjectAuthorDiscuss
16/6/2025
10:31:23
SBTX 17.75p = / SkinBioTherapeutics signs exclusive commercial agreementwith Superdrug for AxisBiotix™ products in the UK
Placing and Subscription to raise £4.1m to support Superdrug agreement; Proposed Retail Offer to existing shareholders of up to £0.62m

AxisBiotix™-Ps Receives US National Psoriasis FoundationSeal of Recognition

16 June 2025 - SkinBioTherapeutics plc (AIM: SBTX), a life science group focused on skin health, announces that it has signed an exclusive UK commercial agreement with Superdrug Stores plc ("Superdrug") (the "Commercial Agreement"), one of the UK's leading beauty and health retailers, related to its AxisBiotix™ food supplements to alleviate the symptoms of inflammatory skin conditions.

In order to provide additional working capital to facilitate and support the Commercial Agreement and future formulation and packaging requirements, the Company has today raised £4.1m (gross) via a placing (the "Placing") and a subscription (the "Subscription") of 24,117,645 new ordinary shares of 1p (the "New Ordinary Shares") at 17 pence each (the "Issue Price"). The Issue Price represents no discount to the Company's closing bid-price on 13 June 2025 (being the last practicable day prior to the publication of this Announcement). The Placing is being made available to certain institutional investors, including Premier Miton. Under the terms of the Subscription David Brierwood (who currently holds 5.51% of the Company's ordinary shares) has subscribed for a total of £600,000 which equates to 3,529,411 New Ordinary Shares as part of the fundraising, at the Issue Price and at the same time as the Placing.

In addition, the Company is proposing a retail offer to all existing shareholders for up to 3,617,647 New Ordinary Shares at the Issue Price to raise up to an additional £615,000 (before expenses). Further details are set out below.

The Company is also pleased to announce that it has been granted Seal of Recognition by the US National Psoriasis Foundation (NPF) and inclusion in its approved product directory - a most important industry validation for commercial traction in the USA.

Superdrug agreement

Superdrug is one of the UK's leading beauty and health retailers. The Commercial Agreement is on an exclusive basis for the sale of both AxisBiotix-Ps and AxisBiotix-Ac in Superdrug's UK stores for two years. This will be the first time AxisBiotix for acne has been made commercially available. SkinBioTherapeutics retains the worldwide rights to direct online retail sales of both products via the AxisBiotix website and Amazon.

The initial roll-out of both AxisBiotix products will occur in early September 2025 in Superdrug stores, which typically have higher sales of medicated skincare relative to the rest of its group. A phased roll-out to the rest of Superdrug's UK store portfolio is scheduled to commence in Spring 2026.

Given the extremely short lead time for manufacture and delivery of both products to meet the stringent launch deadline, they will initially be sold in powder form. However, the longer term intention is to deliver a capsule and/or gum format. SkinBioTherapeutics will be working on these new formulations and looks to acquire additional capital equipment for encapsulation and blister-packaging to keep this work in-house.

Stuart Ashman, CEO of SkinBioTherapeutics said:

"The commercial agreement with Superdrug is a major milestone as we sign our first national high street agreement. We have been in discussions for a considerable period of time to determine the right way to promote, package and roll-out both of the AxisBiotix products. Importantly, we retain the worldwide rights to sell the products ourselves directly online and via Amazon, and remain in control over how our products are promoted. We have a very tight timeframe to produce and deliver the stock required for launch and to ensure that we have sufficient levels going forward to avoid a back-order position."

US National Psoriasis Foundation ("NPF")

SkinBioTherapeutics has also been in active dialogue for some time with the NPF, the leading non-profit organisation representing individuals with psoriasis and psoriatic arthritis in the USA. The NPF has granted AxisBiotix-Ps Seal of Recognition and inclusion in its approved product directory Here.

According to the NPF, the Seal of Recognition "…highlights and recognizes products created or intended to be non-irritating and safe for those living with psoriatic disease. The directory specifically recognizes products that are safe as part of a daily skincare routine for sensitive skin or suitable for those with joint mobility limitations."

This official recognition is important industry validation of AxisBiotix™-Ps and opens up potential new markets for the product.

Placing and WRAP Retail Offer

In order to support the initial launch of AxisBiotix™ products with Superdrug this Autumn and to acquire the encapsulation and packaging equipment to support the development of a capsule format, the Board decided to undertake the Placing, thus allowing existing funds to continue to be deployed as envisaged in the other areas of the Group. The proceeds of the Placing will also be used for marketing purposes and to further raise brand awareness of AxisBiotix™.

In addition to the Placing and Subscription, the Company announces that there will be a separate retail offer to existing shareholders via the Winterflood Retail Access Platform ("WRAP") to raise up to £615,000 (before expenses) at the Issue Price (the "WRAP Retail Offer", and together with the Placing and the Subscription, the "Fundraising"). This represents 15% of the Placing and the Subscription and provides existing shareholders in the Company an opportunity to participate in the Fundraising.

Those investors who subscribe for new Ordinary Shares pursuant to the WRAP Retail Offer (the "WRAP Retail Offer Shares") will do so pursuant to the terms and conditions of the WRAP Retail Offer contained in a separate announcement to be released by the Company. The WRAP Retail Offer is subject to a minimum subscription of £100 per investor and will be open to existing shareholders of the Company within the United Kingdom. A separate announcement will be made by the Company regarding the WRAP Retail Offer and its terms in due course ("WRAP Retail Offer Announcement").

Those investors who subscribe for WRAP Retail Offer Shares pursuant to the WRAP Retail Offer will do so pursuant to the terms and conditions contained in the WRAP Retail Offer Announcement. The WRAP Retail Offer will be conditional on completion of the Placing but the Placing is not conditional upon completion of the WRAP Retail Offer. For the avoidance of doubt, the WRAP Retail Offer does not form part of the Placing.

The Placing, Subscription and the WRAP Retail Offer are being conducted using the existing authorities to issue and allot new ordinary shares for cash and disapply pre-emption rights, which the Directors were granted at the annual general meeting of the Company held on 27 December 2024.

It is expected that admission of the New Ordinary Shares to be issued pursuant to the Placing and Subscription to trading on AIM ("Admission") will occur and that dealings will commence at 8.00 a.m. on 24 June 2025. These New Ordinary Shares will rank pari passu with the Company's existing ordinary shares. The New Ordinary Shares are equivalent to approximately 9.34 per cent. of the Company's enlarged issued share capital (ignoring any New Ordinary Shares to be issued pursuant to the WRAP Retail Offer).

In due course, an application will be made for any New Ordinary Shares issued pursuant to the WRAP Retail Offer to be admitted to trading on AIM.

Total Voting Rights

Following Admission, the Company will have 258,192,272 Ordinary Shares in issue and no ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 258,192,272.

master rsi
16/6/2025
09:56:36
AI is disrupting the advertising business in a big way — industry leaders explain how - JUN 15 20251:41 Ryan Browne
AI disruption is “unnerving investors in every industry, and it’s totally disrupting our business,” WPP’s outgoing boss Mark Read told CNBC.

The advertising market is under threat from emerging generative AI tools that can be used to generate pieces of content at rapid pace.

The advertising industry is undergoing a “huge transformation” due to AI’s disruptive effects, according to Publicis Groupe CEO Maurice Levy.

Artificial intelligence is shaking up the advertising business and “unnerving” investors, one industry leader told CNBC.

“I think this AI disruption ... unnerving investors in every industry, and it’s totally disrupting our business,” Mark Read, the outgoing CEO of British advertising group WPP
, told CNBC’s Karen Tso on Tuesday.

The advertising market is under threat from emerging generative AI tools that can be used to materialize pieces of content at rapid pace. The past couple of years has seen the rise of a number of AI image generators, including OpenAI’s DALL-E, Google’s Veo and Midjourney.

In his first interview since announcing he would step down as WPP boss, Read said that AI is “going to totally revolutionize our business.”

“AI is going to make all the world’s expertise available to everybody at extremely low cost,” he said at London Tech Week. “The best lawyer, the best psychologist, the best radiologist, the best accountant, and indeed, the best advertising creatives and marketing people often will be an AI, you know, will be driven by AI.”

Read said that 50,000 WPP employees now use WPP Open, the company’s own AI-powered marketing platform.

master rsi
16/6/2025
09:29:32
LST 3.60p = / Appointment of Nominated Adviser and Broker

Light Science Technologies Holdings plc (AIM: LST), the innovative technology and manufacturing business providing real-world solutions targeting issues including global food security and fire safety, is pleased to announce the appointment of Shore Capital and Corporate Limited as its Nominated Adviser and Shore Capital Stockbrokers Limited as its Broker with immediate effect.

Simon Deacon, CEO of LSTH, commented: "I would like to take this opportunity to thank Strand Hanson and Oberon Capital for their respective invaluable support and guidance over the years. We are very much looking forward to working with the team at Shore Capital and plan to provide a trading update for H1 2025 in due course."

master rsi
16/6/2025
09:04:31
MARKET REPORT
LONDON MARKET OPEN: Stocks rise, Middle East remains volatile

(Alliance News) - Stock prices in London opened higher on Monday in London, ahead of a busy week for interest rate decisions.

The US Federal Reserve, the Bank of Japan and the Bank of England are all expected to hold rates steady at their respective meetings on Tuesday, Wednesday and Thursday, Swissquote's Ipek Ozkardeskaya said.

In the BoE's case, this is "despite growing concerns over the UK's fiscal path".

And US ambassador to Israel Mike Huckabee said an embassy building in Tel Aviv sustained minor damage from a nearby Iranian missile strike, reporting no injuries to US personnel.

AFP images showed gutted buildings in the coastal hub of Tel Aviv, after Israel's army warned people to take cover from incoming Iranian missiles. Huckabee said on X. He said the US embassy in Jerusalem would remain closed on Monday as orders to "shelter in place [are] still in effect".

The FTSE 100 index opened up 15.07 points, 0.2%, at 8,865.70. The FTSE 250 was up 35.67 points, 0.2%, at 21,209.00, and the AIM All-Share was up 1.00 points, 0.1%, at 762.43.

The Cboe UK 100 was up 0.3% at 883.84, the Cboe UK 250 was up 0.3% at 18,711.66, and the Cboe Small Companies was up slightly at 17,083.36.

On the FTSE 100, Entain jumped 7.0% after upgrading annual revenue and Ebitda guidance for its BetMGM business.

Glencore rose 1.4%. The miner confirmed that all regulatory closing conditions have been satisfied for the cash-and-share sale of its interest in Viterra to Bunge, which Glencore expects will close next month.

On the FTSE 250, Assura was 0.1% higher.

It noted Primary Health Properties' announcement on Friday revising the terms of its cash-and-share takeover offer. It said its board is reviewing the changes "and will continue to engage in extensive shareholder consultation". PHP was up 0.1%.

In smaller caps, Costain jumped 8.1%.

The construction and engineering firm announced its intention to launch a GBP10 million buyback programme, and confirmed that trading remains in line with the board's expectations for 2025.

In European equities on Monday, the CAC 40 in Paris was up 0.3%, while the DAX 40 in Frankfurt was up 0.3%.

The pound was quoted at USD1.3585 early on Monday in London, lower compared to USD1.3591 at the equities close on Friday. The euro stood at USD1.1579, higher against USD1.1560. Against the yen, the dollar was trading higher at JPY144.25 compared to JPY144.01.

In Asia on Monday, the Nikkei 225 index in Tokyo was up 1.3%. In China, the Shanghai Composite was up 0.4%, while the Hang Seng index in Hong Kong was up 0.7%. The S&P/ASX 200 in Sydney closed marginally higher.

In the US on Friday, Wall Street ended lower, with the Dow Jones Industrial Average down 1.8%, the S&P 500 down 1.1% and the Nasdaq Composite down 1.3%.

The yield on the US 10-year Treasury was quoted at 4.46%, widening from 4.42%. The yield on the US 30-year Treasury was quoted at 4.95%, widening from 4.90%.

Brent oil was quoted higher at USD74.76 a barrel early in London on Monday from USD73.61 late Friday.

"Some analysts argue that escalating conflict could ultimately dampen global growth and cap oil's upside," Ozkardeskaya said. "Others believe rising prices could encourage shale producers to boost output. Realistically, the risk of disruptions in the Strait of Hormuz – a critical chokepoint for a third of global oil flows – means the balance of risks remains tilted to the upside.

"Many experts warn that current tensions between Israel and Iran look more serious than in recent years, and that a broader conflict could send oil prices north of USD100 per barrel."

Gold was quoted lower at USD3.413.90 an ounce against USD3,427.50.

Still to come on Monday's economic calendar, the New York State manufacturing index is due in the afternoon.

master rsi
16/6/2025
08:30:48
NOTE - The placing in Pounds represents 15.81p ( 8.9% discount to Friday's close ) - A$6.60 (~£3.162) : 50 for 1 on the 19 June.

GGP 16.80p -0.32p / - Greatland Resources successfully completes ASX bookbuild
Final offer size of A$490 million, comprising A$50 million new sharesand A$440 million secondary offer.
Highlights

§ Greatland Resources has received firm commitments to raise a total of ~A$50 million (~£23.9 million1) (before costs) at a Final Offer Price of A$6.60 (~£3.162) per share under the Australian Primary Offer.

§ In addition, SaleCo has received firm commitments for the sale of 66,729,557 Greatland Resources Shares at the Final Offer Price, resulting in gross sale proceeds of ~A$440.4 million (~£210.6 million1) (before costs).

§ The Australian Offering received exceptionally strong demand from a range of existing and new high-quality investors, with the Final Offer Price of A$6.60 being the top end of the indicative price range of the ASX bookbuild.

§ At the Final Offer Price, Greatland Resources would be capitalised at A$4.4 billion (~£2.1 billion1)

§ The ASX listing is expected to enhance the Company's capital markets profile, facilitate greater equity research and institutional ownership, provide access to additional deep pools of capital, and create greater flexibility to pursue the Company's growth strategy.

Commentary

Greatland Resources Limited ("Greatland Resources" or the "Company") is pleased to advise that it has received firm commitments for the issue of 7,575,758 ordinary shares in Greatland Resources ("Greatland Resources Shares") at a Final Offer price of A$6.60 (~£3.162) per share ("Final Offer Price") to raise ~A$50 (~£23.91) million (before costs) pursuant to a prospectus dated 30 May 2025 ("Australian Primary Offer"). Proceeds raised will primarily be used on general operating, corporate expenses, working capital and costs of the offer.

In addition, Bright SaleCo Limited ("SaleCo"), a special purpose vehicle incorporated to enable the sale of up to 66,729,557 Greatland Resources Shares by Newmont NOL Pty Limited (a subsidiary of Newmont Corporation) ("Newmont"), has received firm commitments for the sale of the full 66,729,557 Greatland Resources Shares at the Final Offer Price, resulting in total gross proceeds for Newmont of ~A$440.4 million (~£210.6 million1) (before costs) ("Australian Secondary Offer", which together with the Australian Primary Offer, is the "Australian Offering"). The sale of Greatland Resources Shares under the Australian Secondary Offer represents half of the Greatland Resources Shares that Newmont will be issued pursuant to the scheme of arrangement under Part 26 of the UK Companies Act ("UK Scheme") to implement the corporate re-organisation of the Greatland group under Greatland Resources.

The Final Offer Price represents approximately: 2,3§ 8.9% discount to the last close on Friday, 13 June 2025;

§ 3.1% discount to the 5-day volume weighted average price ("VWAP"), up to and including Friday, 13 June 2025;

§ 19.5% premium to the closing share price on 22 May 2025, the day prior to lodgment of the Company's original prospectus.

The Australian Offering is conditional, among other things, on the UK Scheme being sanctioned by the UK Court and becoming effective. The Greatland Resources Shares, when issued, will rank pari passu with the existing Greatland Resources Shares.

Greatland Resources has applied for Greatland Resources to be admitted to the Official List of the ASX and the Greatland Resources Shares are expected to be quoted on the ASX and commence trading on a normal settlement basis on the ASX at 1.00 p.m. (Sydney time) / 4.00 a.m. (London time) on 24 June 2025. In addition, an application will be made to the London Stock Exchange for the Greatland Resources Shares, including those to be issued pursuant to the Australian Primary Offer, to be admitted to trading on AIM. Admission of the Greatland Resources Shares to trading on AIM is expected to take effect at 8.00 a.m. on 23 June 2025.

In respect of the ASX listing and Australian Offering, BofA Securities, Barrenjoey and Canaccord are acting as Joint Lead Managers. Sternship Advisers and Argonaut Securities are acting as Co-Managers.

Notes:
1. Calculated based on A$:£ of 0.4781 as at the last close on AIM on Friday, 13 June 2025.

2. Calculated based on A$:£ of 0.4781 as at the last close on AIM on Friday, 13 June 2025. Final Offer Price reflects the effective 20 to 1 share consolidation as part of the UK Scheme and is equivalent to a price of 15.78 pence per share in Greatland Gold plc ("GGP").

3. Calculated based on GGP's closing share price of 17.32 pence on AIM on Friday, 13 June 2025, and the 5-day VWAP on AIM, up to and including Friday, 13 June 2025 of approximately 16.28 pence.

Managing Director, Shaun Day, commented:

"The exceptional demand received for the Australian Offering is testament to the quality and opportunity of Greatland's Telfer mine and world-class Havieron brownfield development project, and the significant progress already made by our team in successfully integrating, operating and optimising these assets since we acquired full ownership in December 2024.

The Australian Offering was strongly supported by existing shareholders and will also introduce a range of new, high-quality domestic and international investors to the register. The ASX is a natural listing venue for Greatland and we look forward to debuting on the exchange as a leading new Australian gold-copper producer.

On behalf of the Greatland Resources Board and management team, I would like to warmly welcome our new shareholders and thank all of our existing shareholders for their long-standing support. We look forward to now finalising the corporate reorganisation under Greatland Resources and commencement of trading on both the ASX and AIM.

Directors' participation in the Australian Offering

The following directors of Greatland Gold have given commitments to subscribe for the following Greatland Resources Shares at the Final Offer Price as part of the Australian Offering.

master rsi
16/6/2025
08:08:42
FTSE

UP by 17 points

master rsi
15/6/2025
21:20:10
Sunday papers:

Share tips, comment and bids

The Observer: Donald Trump on Friday signed an executive order paving the way for a Nippon Steel investment in US Steel, so long as the Japanese company complies with a ‘national security agreement’ submitted by the federal government.

The Sunday Times: Metro Bank has received a takeover approach from the private equity house that owns Shawbrook Bank in a move that could add to the exodus of companies from the London Stock Exchange.

The Sunday Telegraph (Comment): Sadiq Khan’s London is crumbling. Reeves may have just sealed its fate.

The Sunday Times (Comment): Boeing chiefs toasted a ‘turnaround year’. Then disaster struck again.

The Sunday Times (Comment): Jobs market is flashing a warning sign to Rachel Reeves.

master rsi
15/6/2025
20:27:46
Sunday papers:

Top stories

The Sunday Times: A fraud investigation into HS2 has been started by the taxman over allegations of ‘large-scale’ financial impropriety.

The Sunday Times: Australian infrastructure giant Macquarie is closing in on a multibillion-pound swoop for Birmingham, Bristol and London City airports.

master rsi
15/6/2025
11:23:17
The Master RSI just copies and pasted from elsewhere

Nothing about RSI

Master RSI ? More like master bater

travis walton
14/6/2025
21:28:43
LA Times Studios Joins S4 Capital’s Monks at the Cannes Lions Festival of Creativity - June 12, 2025

The activation at Les Monks Café will feature conversations with influential leaders and brand innovators, June 16-19.

LA Times Studios, in partnership with global marketing and technology services company Monks, will make its Cannes debut at the 72nd annual Cannes Lions International Festival of Creativity, hosting engaging conversations and special programming at the Les Monks Café, June 16-19.

Located at La Biererie, across from the Palais des Festivals, programming by LA Times Studios and Monks will welcome influential leaders and brand innovators to Les Monks Café for meaningful conversations about building, sustaining and refreshing brand identity through storytelling.

“Cannes Lions is a premier festival for the advertising and creative industries, and we’re thrilled to be collaborating with Monks on this dynamic activation,” said Anna Magzanyan, president of LA Times Studios. “We’re bringing together some of the most visionary minds in technology, marketing and creative advertising to share their insights and to create an opportunity for networking among industry leaders.”... more

master rsi
13/6/2025
23:44:05
US close: Stocks lower amid heightened Middle East tensions

(Sharecast News) - Wall Street stocks closed lower on Friday as market participants reacted to news that Israel launched an airstrike on Iran.

At the close, the Dow Jones Industrial Average was down 1.79% at 42,197.79,
while the S&P 500 lost 1.13% to 5,976.97,
and the Nasdaq Composite saw out the session 1.30% weaker at 19,406.83.

The Dow closed 769.83 points lower on Friday, more than reversing gains recorded in the previous session (101.85) following the publication of last month's producer price index from the Bureau of Labor Statistics.

Stocks headed south after Israel's defence minister declared a special state of emergency following an Israeli attack on Iran, targeting the country's nuclear facilities and missile factories.

master rsi
13/6/2025
23:31:14
Best performing shares ( UPS ) during JUNE


Share
Mid
Highest
% Change
Rank


EEE
10.90
22.25
104.13
1


HE1
0.835
1.030
23.35
2


BOOM
362.50
402.50
11.03
3


LST
3.65
4.00
9.59
4


SFOR
23.675
25.65
8.34
5


SBTX
18.75
19.00
1.33
6

master rsi
13/6/2025
22:16:30
Smarter Web to raise GBP15 million via institutional placing

The Smarter Web Company PLC - Surrey, England-based provider of web design - announces a placing by Tennyson Securities and Peterhouse Capital Ltd to institutional investors at 180 pence per share. The accelerated bookbuild aims to raise a minimum of GBP15 million.

Smarter Web says its growth strategy is focused on: organic growth opportunities around existing, established services; an acquisition strategy intended to accelerate scale; and the adoption of a bitcoin treasury policy into its strategy.

Current stock price: USD2.68, up 4.3% in London on Friday

master rsi
13/6/2025
21:52:18
DOW

Finished well down with 769 points

master rsi
13/6/2025
16:42:14
BFC THREAD

cielos - 22 Mar 2007 - 00:05:12 - 35479 of 37294 Biofuels Corporation Charts - BFC
Master RSI

You are the King or maybe the Master on timing, keep it up

aimgamblerssupportgroup
Chat Pages: 220  219  218  217  216  215  214  213  212  211  210  209  Older

Top Brokers in the UK

Spread Bet
CFD
Forex
Share

Your Recent History

Delayed Upgrade Clock